Concepedia
Statistics
Publications
21
Citations
1K
H-Index
18
Active since
1987
Affiliations
Sanofi (France)(Current)
Institut National de la Transfusion Sanguine
Hôpital Purpan
F. Dol is an author at Sanofi (France) specializing in pharmacology, pharmacodynamics, and medicine.
Publications per year
1987–1999
Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel
Pierre Savi, Jean‐Marc Herbert, A. M. Pflieger et al. · Biochemical Pharmacology · 1992 · 212 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
Jean‐Marc Herbert, A. Bernat, F. Dol et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 98 citations
Medicine, Medicinal Chemistry, Pharmacology +11
IL‐4 and IL‐13 exhibit comparable abilities to reduce pyrogen‐induced expression of procoagulant activity in endothelial cells and monocytes
Jean‐Marc Herbert, Pierre Savi, M.-Cl. Laplace et al. · FEBS Letters · 1993 · 84 citations
Life Sciences, Immunology, Pharmacology +17
Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor Effect of heparin
Jean‐Marc Herbert, Isabelle Lamarche, F. Dol · FEBS Letters · 1992 · 73 citations · Full text
Life Sciences, Biochemistry, Pharmacology +13
Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells.
Jean‐Marc Herbert, Isabelle Lamarche, V. Prabonnaud et al. · Journal of Biological Chemistry · 1994 · 72 citations · Full text
Life Sciences, Cell Biology, Pharmacology +13
1–5 of 21